Skip to main content
. 2018 Nov 23;10:6227–6236. doi: 10.2147/CMAR.S178979

Table 2.

Cox proportional hazards analysis of CSS and OS for patients with extraskeletal and skeletal Ewing sarcoma

Characteristics CSS OS
HR (95% CI) P-value HR (95% CI) P-value
Race 0.114 0.150
 White Ref. Ref.
 Non-White 1.152 (0.976–1.373) 0.114 1.133 (0.956–1.342) 0.150
Ethnicity 0.120 0.085
 Non-Hispanic Ref. Ref.
 Hispanic 1.122 (0.970–1.296) 0.120 1.131 (0.983–1.300) 0.085
Age (years) <0.001 <0.001
 0–19 Ref. Ref.
 20–39 1.607 (1.426–1.811) <0.001 1.614 (1.438–1.812) <0.001
 ≥40 2.536 (2.153–2.988) <0.001 2.797 (2.398–3.262) <0.001
Sex 0.027
 Male Ref. Ref.
 Female 0.882 (0.788–0.986) 0.027 0.870 (0.781–0.968) 0.011
Year of diagnosis <0.001 <0.001
 1973–1979 Ref. Ref.
 1980–1989 0.847 (0.670–1.070) 0.164 0.836 (0.670–1.043) 0.113
 1990–1999 0.635 (0.503–0.800) <0.001 0.650 (0.522–0.808) <0.001
 2000–2009 0.581 (0.468–0.722) <0.001 0.570 (0.464–0.701) <0.001
 2010–2014 0.501 (0.389–0.646) <0.001 0.507 (0.398–0.646) <0.001
Origin 0.025 0.018
 Skeletal Ref. Ref.
 Extraskeletal 1.157 (1.018–1.315) 0.025 1.160 (1.026–1.312) 0.018
Histologic type
 EWS Ref. Ref.
 PNET/Askin 1.008 (0.844–1.205) 0.926 1.093 (0.949–1.258) 0.217
Size (cm) <0.001 <0.001
 ≤10 Ref. Ref.
 >10 1.619 (1.390–1.885) <0.001 1.590 (1.371–1.844) <0.001
 Unknown 1.289 (1.121–1.482) <0.001 1.308 (1.145–1.495) <0.001
Lymph node 0.396 0.334
 Negative Ref. Ref.
 Positive 1.254 (0.903–1.739) 0.176 1.261 (0.922–1.724) 0.147
 Unknown 1.037 (0.911–1.180) 0.584 1.009 (0.893–1.141) 0.881
Stage <0.001 <0.001
 Non-distant Ref. Ref.
 Distant 2.712 (2.413–3.048) <0.001 2.523 (2.255–2.824) <0.001
 Unknown 1.253 (1.015–1.547) 0.036 1.245 (1.022–1.517) 0.030
Surgery <0.001 <0.001
 No Ref. Ref.
 Yes 0.564 (0.502–0.633) <0.001 0.572 (0.511–0.639) <0.001
 Unknown 0.776 (0.575–1.048) 0.098 0.789 (0.593–1.050) 0.105

Abbreviations: CSS, cancer-specific survival; EWS, Ewing sarcoma; OS, overall survival; PNET, peripheral primitive neuroectodermal tumors; Ref., reference.